首页> 外文会议>NSTI nanotechnology conference and expo >Cerium Oxide Nanoparticles Protect Against MPTP-Induced Dopaminergic Neurodegeneration In A Mouse Model For Parkinson's Disease
【24h】

Cerium Oxide Nanoparticles Protect Against MPTP-Induced Dopaminergic Neurodegeneration In A Mouse Model For Parkinson's Disease

机译:氧化铈纳米粒子可防止在小鼠模型中用于帕金森病的小鼠模型中的MPTP诱导的多巴胺能神经变性

获取原文

摘要

Cerium oxide nanoparticles (CeONP) are regenerative free radical scavengers that protect against oxidative stress. Previous work from this lab has shown that CeONP extend cell (mixed brain, neuronal, endothelial) and organism (Drosophila) longevity, protect against oxidative stress and free radical production, and are effective in tissue culture models of neurodegenerative disorders. Given that Parkinson's Disease (PD) is strongly associated with oxidative stress, and that CeONP act as free radical scavengers, it was hypothesized that CeONP may be a promising disease-modifying therapy for treatment of PD. Here, we demonstrate for the first time, that CeONP preserve striatal dopamine and protect dopaminergic neurons in the substantia nigra, in the MPTP-mouse model of Parkinson's Disease. This work demonstrates the potential for CeONP as a novel nanopharmaceutical for the treatment of neurodegenerative disorders.
机译:氧化铈纳米颗粒(Cearp)是可再生自由基清除剂,可防止氧化应激。从本实验室的以前的工作表明,CeOnP扩展了细胞(混合大脑,神经元,内皮)和生物(果蝇)寿命,防止氧化应激和自由基产生,并且在神经变性障碍的组织培养模型中有效。鉴于帕金森病(Pd)与氧化应激强烈有关,并且Ceonp作为自由基清除剂,它被假设为Ceonp可能是治疗Pd的有前途的疾病修饰治疗。在这里,我们首次证明,CeOnp保存纹状体多巴胺并保护在帕金森病的MPTP-小鼠模型中的体内NIGRA中的多巴胺能神经元。这项工作展示了CEONP作为一种用于治疗神经变性障碍的新型纳米药物的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号